Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Absolute Bioavailability of Lesinurad in Healthy Males
NCT02039700Phase 1Completed
- Sponsor
- Ardea Biosciences, Inc.
- Start
- Jan 2014
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of lesinurad in gout, sponsored by Ardea Biosciences, Inc. Primary endpoints: Pharmacokinetics profile of lesinurad from plasma and Pharmacokinetics profile of [14C]lesinurad from plasma. Started Jan 2014; status: completed.
02
Drugs
lesinurad
03
Conditions
gout
Beyond the preview
Go deeper on NCT02039700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02039700.